Washington DC 28 Feb 2012 The Federal Ministry of Health of Nigeria announced on Tuesday a new collaboration with the Global Access to Pain Relief Initiative to make essential pain medicines available in Nigeria for the first time in two years
GAVI's Board has taken the first steps towards the introduction of human papillomavirus (HPV) vaccines in developing countries, it was announced on 17th November.
The Liga Contra el Cáncer Cajamarca received a CCI seed grant for their project called: "Early detection and monitoring from patients with premalignant and malignant lesions of cervix uteri in Cajamarca-Peru"
The GAVI Alliance will be offered the HPV quadrivalent vaccine from Merck at an indicative price of USD 5 per dose, following a landmark announcement from the pharmaceutical company on 6th June.
HCJMRI and Prayas, Pune in collaboration and guidance from IARC, have initiated a project to prevent cervical cancer in HIV infected women with support from UICC through a CCI grant.
The government of Rwanda announced the launch of a national cervical cancer prevention program that incorporates prevention by vaccination against the Human Papillomavirus (HPV) as well as early detection for HPV infection.
Named after the Spanish Principality in which the meeting was held, this new call to action addresses the known and preventable environmental & occupational causes of cancer, and identifies required policies to reverse the trend of their occurrence.
